Bovine Parotid Gland Extract

Bovine parotid gland extract is a glandular supplement derived from cattle salivary tissue containing carbonic anhydrase 6 and BPIFA2B protein. Its proposed mechanisms involve salivary enzyme activity and mucosal support, though no controlled human trials have validated these effects.

Origin & History

Bovine Parotid Gland Extract is derived from the parotid salivary glands of cows (Bos taurus), which produce 50-150 liters of saliva daily. The extract is typically produced through homogenization in phosphate-buffered saline (PBS), centrifugation at 4°C (8500×g), and storage at -80°C.

Historical & Cultural Context

No historical or traditional medicine uses are documented in the available sources for bovine parotid gland extract. The research provides no information about use in Ayurveda, Traditional Chinese Medicine, or other traditional healing systems.

Health Benefits

• No human health benefits have been clinically studied or documented in the available research
• Contains carbonic anhydrase 6, which stabilizes pH in bovine saliva but effects in humans are unstudied
• Contains BPIFA2B protein, though human applications remain unresearched
• Mouse model studies (not bovine) showed parotid extracts affected aggression signaling, but relevance to humans unknown
• No evidence-based health claims can be made from current research

How It Works

Bovine parotid gland extract contains carbonic anhydrase 6, a zinc-metalloenzyme that catalyzes the reversible hydration of carbon dioxide to bicarbonate, stabilizing local pH in salivary and potentially mucosal environments. BPIFA2B, a palate-lung-nasal epithelium clone protein, is hypothesized to play a role in mucosal innate immunity and lipid binding at epithelial surfaces, though receptor-level interactions in human tissue have not been characterized. Whether orally ingested bovine-derived carbonic anhydrase 6 survives gastrointestinal proteolysis to exert enzymatic activity in humans remains undemonstrated.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses were identified for bovine parotid gland extract. Available research focuses solely on bovine saliva composition analysis and mouse model studies using mouse (not bovine) parotid extracts.

Clinical Summary

No published human clinical trials exist evaluating bovine parotid gland extract for any health outcome, making evidence-based efficacy claims impossible at this time. Preclinical mouse model studies have explored salivary gland biology, but sample sizes, protocols, and outcomes from these animal studies have not been translated into human interventional research. The extract has historically appeared in glandular therapy formulations promoted by practitioners of organotherapy, a tradition lacking modern randomized controlled trial support. The current body of evidence does not permit conclusions about effective dosage, therapeutic targets, or meaningful clinical benefit in humans.

Nutritional Profile

Bovine parotid gland extract is a protein-rich glandular tissue derivative with a composition reflective of exocrine gland tissue. Protein content is the dominant macronutrient, estimated at 60-80% of dry weight, comprising enzymatic and structural proteins including carbonic anhydrase 6 (CA6, also called gustin), BPIFA2B (a secretory protein in the PLUNC family), proline-rich proteins, mucin glycoproteins, and amylase. Lipid content is modest, estimated at 5-15% of dry weight, consisting primarily of phospholipids from cell membranes. Carbohydrates are present largely as glycoprotein-bound oligosaccharides rather than free sugars. Zinc is a notable micronutrient due to its role as a cofactor in CA6 (one zinc ion per molecule); glandular tissue generally concentrates zinc at levels of 15-40 mcg/g dry weight. Calcium and magnesium are present as structural and enzymatic cofactors, estimated at 200-500 mcg/g and 100-300 mcg/g dry weight respectively. Iron is present at trace levels (~10-20 mcg/g). B vitamins, particularly B2 (riboflavin) and B3 (niacin), are present at low concentrations typical of organ tissue (~2-5 mcg/g and ~40-80 mcg/g dry weight respectively). Bioavailability of intact proteins when taken orally is limited by gastrointestinal proteolysis, meaning most functional proteins are likely degraded to peptides and amino acids before absorption; survival of bioactive peptides is plausible but unconfirmed in human studies. The glycoprotein fraction may partially resist digestion. No standardized concentration data exists for commercial extracts.

Preparation & Dosage

No clinically studied dosage ranges, forms (extract, powder, standardized), or standardization details are available due to absence of human clinical data. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of research

Safety & Interactions

No systematic human safety studies have been conducted on bovine parotid gland extract, so a formal adverse event profile cannot be established. Individuals with known beef or bovine protein allergies face a theoretical risk of allergic reaction, including anaphylaxis, and should avoid this ingredient entirely. There are no documented drug interaction studies; however, enzymatic proteins from glandular sources could theoretically interfere with mucosal drug absorption if enzymatic activity survives digestion. Pregnant and breastfeeding individuals should avoid this supplement due to a complete absence of safety data in these populations.